Literature DB >> 9659967

Stability of vancomycin in an extemporaneously compounded ophthalmic solution.

L C Fuhrman1, R T Stroman.   

Abstract

The stability of vancomycin 31 mg/mL (as the hydrochloride) in an artificial tears solution at -10, 4, 25, and 40 degrees C was studied. Vancomycin power was reconstituted with sterile water for injection to a concentration of 50 mg/mL. Artificial tears solution containing 0.3% hydroxypropyl methylcellulose, 0.1% dextran 70, 0.01% benzalkonium chloride, and 0.05% edetate disodium was used to produce a final concentration of 31 mg/mL. Triplicate solutions for each storage temperature and sampling time were prepared. The solutions were stored at -10, 4, 25, and 40 degrees C. Samples were taken initially and at 3, 7, 10, 21, 30, 45, and 60 days for visual inspection and analysis by high-performance liquid chromatography. All solutions remained clear and colorless at -10, 4, and 25 degrees C throughout the study period. By day 3, crystalline particles formed in the solutions stored at 40 degrees C. No substantial change in pH was observed at any time. At -10 degrees C, the solutions retained more than 90% of their initial vancomycin concentrations throughout the study period. The solutions retained a mean of at least 90% of the initial drug concentration for 21 days at 4 degrees C and for 7 days at 25 degrees C. For the solutions stored at 25 or 40 degrees C, less than 85% of the initial vancomycin concentration remained after 10 and 3 days, respectively. Vancomycin 31 mg/mL (as the hydrochloride) in an artificial tears solution was stable for 45 days at -10 degrees C, 10 days at 4 degrees C, and 7 days at 25 degrees C in the tears solution's original container.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659967     DOI: 10.1093/ajhp/55.13.1386

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  3 in total

1.  Methods for reducing bacterial contamination in the BacT/Alert mycobacterial culture detection system.

Authors:  Kim Dionne; Amy Sweeney; Annie Hedgepeth; Karen Carroll; Nicole Parrish
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

2.  An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding.

Authors:  Pang Chen; Zin Mar; Anthony Giannetti; Susan Hughes; Justine Gilbert; Fang Zhao
Journal:  Hosp Pharm       Date:  2020-11-25

3.  [Vancomycin-based Lowenstein-Jensen selective medium for reducing contamination of mycobacterial cultures by spore-forming bacteria].

Authors:  Michel Kiréopori Gomgnimbou; Babacar Faye; Juliette Tranchot-Diallo; Antoinette Kaboré; Louis Robert Belem; Dezémon Zingué; Adama Sanou; Hervé Hien; Lassana Sangaré
Journal:  Pan Afr Med J       Date:  2020-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.